Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1951 to 1975 of about 5940

Previous 25

Website Changes

04/09/2015

PharmaCyte Biotech`s Novel Approach to Brain Cancer

04/03/2015

Checklist for the Newly Diagnosed

04/03/2015

Musella Foundation issues request for proposals for brain tumor research grants

04/03/2015

Participants needed for a study concerning the emotional aspects of cancer care

03/31/2015

Childhood Cancer Survivorship Conference: Focus on Brain Tumors

03/30/2015

03/30/2015

More events added to National Walk To End Brain Tumors

03/18/2015

Help beat brain cancer by filling out your NCAA Tournament bracket

03/15/2015

Long Island, NY SUPPORT GROUP MEETING FOR BRAIN TUMOR PATIENTS, FAMILY MEMBERS, AND CAREGIVERS

03/15/2015

Y Combinator backs cancer drug combo testing service

03/15/2015

New clinical trials at JFK Brain Tumor Center in Edison, NJ

03/15/2015

2nd Hoops For Hannah Bracket Contest

03/14/2015

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

03/11/2015

Study: Tetanus Shot May Aid Treatment of Deadly Brain Cancer

03/07/2015

03/06/2015

How A Group Of Lung Cancer Survivors Got Doctors To Listen

02/26/2015

Israeli Company Develops Device to Fight Tumor Growth with Electric Fields

02/26/2015

New clinical trial for Glioblastoma using immunotherapy

02/26/2015

Quicker Access to Experimental Drugs

02/26/2015

NW BIO`S PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER APPROVED TO PROCEED IN CANADA AND UNDER WAY AT TWO SITES

02/26/2015

The professor who `cured` his cancer with a cocktail of everyday pills and 20 years on remains disease-free

02/26/2015

Cancer drug first tested in pet dogs begins human trials

02/26/2015

Cancer Immunotherapy presentation

02/25/2015

UCLA 15th Annual Brain Tumor Conference

02/23/2015

Celldex`s Rindopepimut (Rintega(R)) Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma

Our privacy / cookie policy has changed.
Click HERE to read it!